Mizuno Shugo, Hori Tomohide, Iida Taku, Yagi Shintaro, Usui Masanobu, Sakurai Hiroyuki, Isaji Shuji, Shiraki Katsuya, Uemoto Shinji
First Department of Surgery, Mie University School of Medicine, Tsu, Mie, Japan.
Hepatogastroenterology. 2007 Mar;54(74):541-4.
Portal vein thrombosis is a risk factor in patients who require liver transplantation, because it is often difficult to treat portal vein thrombosis, especially when it involves the confluence of the superior mesenteric vein and splenic vein. Since some transplant centers that perform living-donor liver transplantation do not have cryopreserved cadaveric vein grafts available and do not use graft veins that are long enough for a jump graft, it is difficult to reconstruct the portal vein with interpositional vein grafts in patients with portal vein thrombosis. We describe the treatment of portal vein thrombosis with an interpositional vascular graft posterior to the pancreas in a living-donor liver transplantation patient without using a jump graft. This method provided a shorter rout between the donor and recipient portal vein than a jump graft. Our experience suggests that this solution can be helpful in treating portal vein thrombosis.
门静脉血栓形成是需要肝移植患者的一个危险因素,因为门静脉血栓形成往往难以治疗,尤其是当它累及肠系膜上静脉和脾静脉汇合处时。由于一些开展活体供肝肝移植的移植中心没有可供使用的冷冻尸体静脉移植物,且不使用足够长的移植物静脉进行搭桥移植,因此对于门静脉血栓形成的患者,很难采用间置静脉移植物重建门静脉。我们描述了在一名活体供肝肝移植患者中,不使用搭桥移植,而是在胰腺后方采用间置血管移植物治疗门静脉血栓形成的方法。与搭桥移植相比,这种方法在供体和受体门静脉之间提供了一条更短的路径。我们的经验表明,这种解决方案有助于治疗门静脉血栓形成。